JRGD:XETRA:XETRA-JPMorgan ETFs (Ireland) ICAV - Global Research Enhanced Index Equity UCITS ETF - USD (dist) (EUR)

ETF | Others |

Last Closing

USD 43.04

Change

0.00 (0.00)%

Market Cap

USD 2.00M

Volume

1.02K

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-09-14 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
XM1D:XETRA Xtrackers MSCI Japan UCITS ETF..

-0.17 (-0.34%)

USD 502.95B
LCUJ:XETRA Lyxor Core MSCI Japan (DR) UCI..

-0.06 (-0.35%)

USD 191.96B
PRAJ:XETRA Amundi Index Solutions - Amund..

-0.10 (-0.36%)

USD 177.46B
PR1J:XETRA Amundi Prime Japan UCITS ETF D..

-0.07 (-0.23%)

USD 177.46B
XDJP:XETRA Xtrackers Nikkei 225 UCITS ETF..

-0.08 (-0.33%)

USD 157.79B
8R80:XETRA Amundi Index Solutions - Amund..

+1.14 (+0.82%)

USD 102.11B
JARI:XETRA Amundi Index Solutions - Amund..

-0.10 (-0.22%)

USD 98.25B
UIM5:XETRA UBS (Lux) Fund Solutions - MSC..

-0.20 (-0.40%)

USD 85.64B
SXR8:XETRA iShares Core S&P 500 UCITS ETF..

+4.30 (+0.81%)

USD 80.38B
FRCJ:XETRA UBS MSCI Japan Socially Respon..

-0.05 (-0.20%)

USD 79.79B

ETFs Containing JRGD:XETRA

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 15.17% 83% B 81% B-
Dividend Return N/A N/A N/A N/A N/A
Total Return 15.17% 82% B 80% B-
Trailing 12 Months  
Capital Gain 19.47% 78% C+ 77% C+
Dividend Return N/A N/A N/A N/A N/A
Total Return 19.47% 77% C+ 76% C+
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain 7.74% 63% D 61% D-
Dividend Return 7.74% 62% D 59% D-
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 10.00% 60% D- 68% D+
Risk Adjusted Return 77.36% 80% B- 82% B
Market Capitalization 2.00M 1% F 1% F

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

What to not like:
Low market capitalization

This is among the smaller entities in its sectors with below median market capitalization. That may make it less stable in the long run unless it has a unique technology or market which can help it grow or get acquired in future.